Diligence memo · auto-generated · as of July 2, 2026
Genomedx Inc.
Genomedx Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Genomedx Inc. operates in Other Health Care, based in SAN DIEGO.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Genomedx Inc. has raised $73M in disclosed capital across 9 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $25M on 2016-02-24.
Most recent recorded round closed around 2020-05-15.
Valuation (modeled)modeled
Provath models Genomedx Inc. at approximately $176M (range $19M–$678M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.47× the median modeled value of Series B Other Health Care companies in 2019–2021 (78 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 6 months.
Last raise 6.1 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.6× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 94% of Other Health Care peers (5377 compared).
Modeled value ranks above 86% of those peers.
Closest niche peers: KSMS Holdings, LLC, Infab HoldCo, Inc., Aquity Holdings, Inc., MHH Management Holdco, LLC, Earli Inc..
Peoplefiled
24 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.